Zhida Wang

Zhejiang Provincial People's Hospital

Papers

1

Total Citations

4

H-Index

1

About

Dr. Zhida Wang is a pioneering urologic surgeon whose research focuses on advancing minimally invasive techniques for renal cancer treatment, particularly through the integration of interventional radiology and robotic surgery. His most notable contribution is the development and clinical validation of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) following preoperative superselective transarterial embolization (STE). In a landmark 2023 study, Dr. Wang demonstrated the feasibility and safety of this combined approach in 32 patients with T1 renal tumors, showing that STE effectively devascularizes tumors before surgery, enabling bloodless resection without renal artery clamping. This technique preserves maximum renal function by eliminating warm ischaemia time, a critical advantage over conventional partial nephrectomy. While his work has garnered early citations (4), its clinical significance is substantial, offering a paradigm shift in nephron-sparing surgery. Dr. Wang’s research bridges interventional radiology and robotic urology, setting a new standard for functional preservation in renal cancer management. His ongoing work continues to refine this protocol, promising improved outcomes for patients with small renal masses.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago